
We’re excited to launch the new call for applications to join the ICF, HERA’s platform for collaboration across the full lifecycle of medical countermeasures — from R&D to manufacturing, deployment, and uptake.

We’re excited to launch the new call for applications to join the ICF, HERA’s platform for collaboration across the full lifecycle of medical countermeasures — from R&D to manufacturing, deployment, and uptake.

On 4 September, HERA published two new calls for proposals under EU4Health to strengthen Europe’s preparedness against health crises. These calls aim to accelerate the development of innovative diagnostic tools for vector-borne diseases and support the advancement of medical countermeasures.

The survey targets authorities and project developers across 14 EU countries to gather insights on how to improve industrial permitting processes.

Discover HERA's strategic orientations for 2025 in the newly released Work Plan.

Three HERA calls under EU4Health are now open for proposals: Next-Generation Influenza Vaccines, AST PoC Medical Device (AMR), & Mpox Vaccine Clinical Trial

HERA review: Taking stock to reinforce health security in the EU

HaDEA has just published a Prior Information Notice for two upcoming HERA-funded call for tenders under EU4Health.

New HERA study maps global pandemic preparedness structures.

Today marks a significant milestone in the coordinated effort to combat the mpox outbreak as almost 100,000 vaccine doses will arrive in the Democratic Republic of Congo (DRC).

A study exploring the impact of large gatherings on airborne microbial diversity in urban environments is being carried out during the Olympic Games in Paris.